Qiagen QIAsymphony SP Molecular Biology DNA Purification High-Throughput
Qiagen
Details
-
CategoryMolecular Biology
-
Dimension28.0in x 50.0in x 40.0in
-
Serial34790
-
Shipping TypeFreight
-
ManufacturingDoes Not Apply
-
Voltage / Hertz100-240v / 50Hz/60Hz
Description
The Qiagen QIAsymphony SP, designed for professional use, automates the purification of nucleic acids in molecular biology and diagnostic applications. In fair condition, with a damaged side panel, it efficiently handles 1-96 samples in batches, with flexible input formats, and supports real-time and next-generation sequencing applications. Compatible with QIAsymphony DSP kits, it offers customizable protocols, traceability, and LIMS compatibility. Despite some cosmetic wear and inability to test full functionality, it is a versatile full-automation platform enhancing lab capabilities.
Technician comment
The Qiagen QIAsymphony SP powers on, and the robotic arm initializes properly during startup. The touchscreen is bright and responsive. Full functionality could not be tested due to missing login credentials. The left side panel is damaged and does not stay securely attached, The unit is preowned from a laboratory environment and shows cosmetic wear consistent with normal use.
Key Features
- Automated purification of nucleic acids
- Processes 1-96 samples in 4 batches
- Supports volume from smallest forensic to 10 ml
- Compatible with real-time PCR and NGS
- Customizable protocols
- Seamless LIMS integration
Specifications
- Brand: Qaigen
- Model: QIAsymphony SP
- Voltage: 100-240v
- Hertz: 50Hz/60Hz
- Processing Capacity: 1-96 samples
- Max Sample Volume: 10 ml
Weight
Imperial: 470.4 Pounds
Metric: 213.37 Kilograms
Shipping Dimensions
Imperial: 33.6 lb x 60.0 lb x 48.0 lb
Metric: 85.34 cm x 152.4 cm x 121.92 cm
Harmonized Code
9027.80
Harmonized Code Details
9027.80 - Instruments and apparatus for physical or chemical analysis. This code suits the QIAsymphony SP due to its use in nucleic acid purification and molecular diagnostics.
Comments 0
There are currently no public comments.